Skip to main content

Table 3 Selected upregulated genes with oncogenic functions located in amplified chromosomal regions

From: Gene networks and transcriptional regulators associated with liver cancer development and progression

Gene

Chr locus

Amplified in GE1-HCC, %

Amplified in GE2-HCC, %

Amplified in NT, %

Mean fold changea of gene expression in GE1-HCC versus NT

Mean fold changea of gene expression in GE2-HCC versus NT

C1orf35

1q42.13

80

75

15.4

2.15

2.4

HIST2 cluster

1q21

80

75

15.4

No change

2.8–22.2

PARP1

1q42.12

70

66.7

15.4

No change

2.06

KPNA2

17q24.2

50

75

7.7

No change

2.63

BIRC5

17q25.3

50

75

7.7

3.41

34.5

TK1

17q25.3

50

75

7.7

1.69

6.93

E2F1

20q11.2

60

66.7

15.4

1.97

6.43

KIFC1

6p21.3

60

66.7

15.4

No change

9.44

HIST1 cluster

6p21-6p22

60

66.7

15.4

No change

2.6–15.9

UBE2C

20q13.12

60

66.7

15.4

1.64

20.35

RECQL4

8q24

100

66.7

69.2

2.12

6.7

H19

11p15.5

80

41.7

53.8

− 3.06

4.58

SNAR-A3

19q13.33

90

50

46.2

No change

7.72

SNAR-B2

19q13.33

90

50

46.2

No change

15.83

SNAR-D

19q13.33

90

50

46.2

No change

17.5

SNAR-G2

19q13.33

90

50

46.2

No change

17.45

ILF3

19q13.2

90

50

46.2

No change

2.21

PAFAH1B3

19q13.1

90

50

46.2

No change

3.85

  1. Chr chromosome, HCC hepatocellular carcinoma, NT non-tumourous
  2. aOnly statistically significant fold changes are shown